Ziath introduces sample management workflow upgrade
Ziath has introduced an easy upgrade path for the many users of DataPaq 3 sample management software products to its powerful new DP5 suite of products.
If you are not happy with the results below please do another search
Ziath has introduced an easy upgrade path for the many users of DataPaq 3 sample management software products to its powerful new DP5 suite of products.
CytoSMART Technologies has released its first fluorescence cell counter. The CytoSMART Exact FL is an automated, dual fluorescence cell counter with an expanded field of view and unmatched performance.
INTEGRA Biosciences has launched the MINI 96 portable electronic pipette, giving every lab access to significantly increased liquid handling productivity.
Bio-Rad Laboratories has launched their SARS-CoV-2 Variant RT-PCR Assays for research use only (RUO).
C4Diagnostics, a French biotech, has received CE marking for their C4Covid-19 Human for the rapid diagnosis of Covid-19 from a saliva sample. The performance of the test was calculated upon a clinical trial of 1320 participants, carried out in collaboration with Synlab Provence Laboratories. Sensitivity is 86% and specificity is 97.5%.
A large number of COVID-19 diagnostic tests are reliant on detection of viral RNA from buccal swabs by PCR.
Agena Bioscience, has unveiled their MassARRAY® SARS-CoV-2 Variant Panel for Research Use Only (RUO) for the detection of key SARS-CoV-2 virus strains, including the UK (B.1.1.7), South Africa (B.1.351), Brazil (P.1) and Denmark (Cluster 5) variants.
Paradigm4 has unveiled its scalable solution for efficiently working with the Allotrope Data Format (ADF).
AMSBIO has launched a comprehensive range of cytosections that offer a verified, reproducible and renewable source of positive / negative controls where the expression of the target biomarker is confirmed for accuracy and specificity by an immunoassay.
IONTAS and FairJourney Biologics, leaders in the discovery and optimisation of fully human antibodies, have announced the identification of neutralizing antibodies, which bind to multiple emerging SARS-CoV-2 variants. The results, generated from a combination of phage display technology and B-cell receptor repertoire sequencing of hospitalized COVID-19 patients, have identified potent neutralizing antibodies with distinct mechanisms of […]